Cargando…
Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection
OBJECTIVES: We determined the efficacy of fecal microbiota transplantation (FMT) and subsequent changes in fecal microbiota and short-chain fatty acid (SCFA) levels in patients with ulcerative colitis (UC), Crohn’s disease (CD), and recurrent Clostridioides difficile infection (rCDI). METHODS: A fil...
Autores principales: | Osaki, Hayato, Jodai, Yasutaka, Koyama, Keishi, Omori, Takafumi, Horiguchi, Noriyuki, Kamano, Toshiaki, Funasaka, Kohei, Nagasaka, Mitsuo, Nakagawa, Yoshihito, Shibata, Tomoyuki, Ohmiya, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fujita Medical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749495/ https://www.ncbi.nlm.nih.gov/pubmed/35111551 http://dx.doi.org/10.20407/fmj.2020-021 |
Ejemplares similares
-
Safety of Polyethylene Glycol Solution plus Ascorbic Acid for Bowel Preparation for Colonoscopy in Patients with Chronic Kidney Disease
por: Ohmiya, Naoki, et al.
Publicado: (2021) -
Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019) -
Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019) -
Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021) -
Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)